1. Rapid reduction in BCR‐ABL1 transcript predicts deep molecular response in dasatinib‐treated chronic‐phase chronic myeloid leukaemia patients. (16th October 2017) Authors: Murai, Kazunori; Yamaguchi, Kohei; Ito, Shigeki; Miyagishima, Takuto; Shindo, Motohiro; Wakasa, Kentaro; Inomata, Mitsue; Nagashima, Takahiro; Kondo, Takeshi; Fujimoto, Nozomu; Yamamoto, Satoshi; Yonezumi, Masakatsu; Oyake, Tatsuo; Kowata, Shugo; Tsukushi, Yasuhiko; Mine, Takahiro; Meguro, Kuniak... Journal: European journal of haematology Issue: Volume 100:Number 1(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗